New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Elixinol Wellness Limited
EXL.AX
Shape
US Flag

ASX

Unprofitable

EPS improving

Unprofitable

EPS improving

6M

Drug Manufacturers - Specialty & Generic

0.00AUD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-79%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

73%

Quote Panel

Shape
Updated October 15, 2024
1W -20.00 % 1M -20.00 % 3M 33.33 % 1Y -42.86 %

Key Metrics

Shape
  • Market Cap

    6.24M


  • Shares Outstanding

    1.56B


  • Share in Float

    1.46B


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.004


  • Average Volume

    1.09M


  • Beta

    2.23


  • Range

    0.003-0.015


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.elixinolwellness.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.54x

P/S Ratio

0.53x

P/B Ratio

0.1

Debt/Equity

-59.3%

Net Margin

$-0.0

EPS

How EXL.AX compares to sector?

P/E Ratio

Relative Strength

Shape

EXL.AX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$21M

Shape210%

2025-Revenue

0

$19M

Shape-689%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

N/A

-0.34
vs NA

Q2.20

arrow
arrow

N/A

-0.43
vs NA

Q4.20

arrow
arrow

N/A

-0.06
vs -0.34

Q2.21

arrow
arrow

N/A

-0.03
vs -0.43

Q4.21

arrow
arrow

N/A

-0.02
vs -0.06

Q2.22

arrow
arrow

N/A

-0.02
vs -0.03

Q4.22

arrow
arrow

N/A

-0.01
vs -0.02

Q2.23

arrow
arrow

N/A

-0.01
vs -0.02

Q4.23

arrow
arrow

N/A

-0.01
vs -0.01

Q2.24

arrow
arrow

+100%

NA
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

+43%

9.7M  vs 6.8M

Q2.20

arrow
arrow

-55%

7.8M  vs 17.5M

Q4.20

arrow
arrow

-26%

7.2M  vs 9.7M

Q2.21

arrow
arrow

-39%

4.8M  vs 7.8M

Q4.21

arrow
arrow

-36%

4.5M  vs 7.2M

Q2.22

arrow
arrow

-33%

3.2M  vs 4.8M

Q4.22

arrow
arrow

-16%

3.8M  vs 4.5M

Q2.23

arrow
arrow

+7%

3.5M  vs 3.2M

Q4.23

arrow
arrow

+25%

4.8M  vs 3.8M

Q2.24

arrow
arrow

+96%

6.8M  vs 3.5M

Return on EquityShape

status-upQoQ

Q4.20

arrow
arrow

-64%

-0.64
vs -2.54

Q2.21

arrow
arrow

-43%

-0.43
vs -0.64

Q4.21

arrow
arrow

-32%

-0.32
vs -0.43

Q2.22

arrow
arrow

-57%

-0.57
vs -0.32

Q4.22

arrow
arrow

-38%

-0.38
vs -0.57

Q2.23

arrow
arrow

-41%

-0.41
vs -0.38

Q4.23

arrow
arrow

-64%

-0.64
vs -0.41

Q2.24

arrow
arrow

-37%

-0.37
vs -0.64

Institutionnal OwnershipShape

status-upQoQ

Q3.19

arrow
arrow

1

1
vs 1

NA

Q4.19

arrow
arrow

1

1
vs 1

NA

Q1.20

arrow
arrow

1

1
vs 1

NA

Q2.20

arrow
arrow

2

2
vs 1

100%

Q3.20

arrow
arrow

2

2
vs 2

NA

Q4.20

arrow
arrow

1

1
vs 2

-50%

Q1.21

arrow
arrow

1

1
vs 1

NA

Q2.21

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News